Sonova Buys InSound, Eyes Lyric Hearing Aid Sales Of $300 Mil. By 2015
This article was originally published in The Gray Sheet
Executive Summary
Swiss hearing aid maker Sonova expects sales of its newly acquired Lyric "invisible" hearing aid to reach $200 million to $300 million by 2015. The firm acquired Lyric developer InSound Medical on Jan. 6 for $75 million, plus milestone payments